Published in Contact Dermatitis on August 01, 2008
Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol (2005) 3.18
The role of scalp dermoscopy in the diagnosis of alopecia areata incognita. J Am Acad Dermatol (2008) 3.11
Oral lichen planus and malignant transformation: a longitudinal cohort study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2011) 2.47
Videodermoscopy in the evaluation of hair and scalp disorders. J Am Acad Dermatol (2006) 2.38
Scalp hair heterochromia in a 5-year-old child: rare somatic mosaicism? Pediatr Dermatol (2014) 2.05
The cost effectiveness of biologic therapy for the treatment of chronic plaque psoriasis in real practice settings in Italy. BioDrugs (2014) 1.99
Follicular red dots: a novel dermoscopic pattern observed in scalp discoid lupus erythematosus. Arch Dermatol (2009) 1.60
The balance between pro- and anti-inflammatory cytokines is crucial in human allergic contact dermatitis pathogenesis: the role of IL-1 family members. Exp Dermatol (2013) 1.45
Titanium Exposure Outcome in Facial Plastic and Reconstructive Surgery. Plast Reconstr Surg (2017) 1.40
Systemic allergic dermatitis syndrome caused by mercury. Contact Dermatitis (2008) 1.40
Mercury within fine-needle aspiration specimen of a lump in the neck. Br J Oral Maxillofac Surg (2009) 1.37
Psoriasis, psoriatic arthritis, or psoriatic disease? J Rheumatol (2006) 1.19
Drug-induced lupus erythematosus. Arch Dermatol Res (2008) 1.16
Distinguishing androgenetic alopecia from chronic telogen effluvium when associated in the same patient: a simple noninvasive method. Arch Dermatol (2005) 1.14
Finasteride treatment of female pattern hair loss. Arch Dermatol (2006) 1.12
Videodermoscopy of the hyponychium in nail bed psoriasis. J Am Acad Dermatol (2008) 1.07
NSE as a biomarker of mercury exposure. Clin Toxicol (Phila) (2014) 1.07
Oral lichenoid lesions: more than mercury. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2005) 1.05
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis. Haematologica (2010) 1.04
Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. J Am Acad Dermatol (2003) 1.04
Alopecia areata during treatment with biologic agents. Arch Dermatol (2006) 1.03
Bullous fixed drug eruption induced by paracetamol: report of a case. Dermatitis (2006) 1.01
Histological features of peripilar signs associated with androgenetic alopecia. Arch Dermatol Res (2004) 1.00
Contact allergens and irritants in household washing and cleaning products. Contact Dermatitis (2009) 0.99
IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation. Exp Dermatol (2012) 0.97
Permanent alopecia after systemic chemotherapy: a clinicopathological study of 10 cases. Am J Dermatopathol (2011) 0.94
Permanent chemotherapy-induced alopecia: a review. J Am Acad Dermatol (2011) 0.92
Metal sensitivity in patients with orthopaedic implants: a prospective study. Contact Dermatitis (2011) 0.92
Current patch test results with the European baseline series and extensions to it from the 'European Surveillance System on Contact Allergy' network, 2007-2008. Contact Dermatitis (2012) 0.92
LTT-MELISA is clinically relevant for detecting and monitoring metal sensitivity. Neuro Endocrinol Lett (2006) 0.91
Allopurinol hypersensitivity reactions: desensitization strategies and new therapeutic alternative molecules. Inflamm Allergy Drug Targets (2013) 0.90
IL-33 is regulated by TNF-α in normal and psoriatic skin. Arch Dermatol Res (2014) 0.89
Eliciting preferences to inform patient-centred policies: the case of psoriasis. Pharmacoeconomics (2014) 0.88
Periungual and subungual pyogenic granuloma following anti-TNF-α therapy: is it the first case? Dermatol Ther (2013) 0.88
Oral lichen planus: mercury and its kin. Arch Dermatol (2005) 0.87
The European baseline series in 10 European Countries, 2005/2006--results of the European Surveillance System on Contact Allergies (ESSCA). Contact Dermatitis (2009) 0.87
Methylmercury, amalgams, and children's health. Environ Health Perspect (2006) 0.87
Adalimumab-induced psoriasis of the scalp with diffuse alopecia: a severe potentially irreversible cutaneous side effect of TNF-alpha blockers. Inflamm Bowel Dis (2010) 0.86
Noneczematous contact dermatitis. ISRN Allergy (2013) 0.86
EMPACT syndrome associated with phenobarbital. Dermatitis (2013) 0.86
Gelatinase expression at positive patch test reactions. Contact Dermatitis (2002) 0.86
Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database. Eur J Dermatol (2010) 0.86
Patch test triggering recurrence of distant dermatitis: the flare-up phenomenon. CMAJ (2008) 0.85
Secondary syphilis with progressive ocular involvement in an immunocompetent patient. Eur J Dermatol (2009) 0.85
Management of subcutaneous implantation of mercury after broken thermometer. J Am Acad Dermatol (2010) 0.85
Trichomegaly of the eyelashes during therapy with epidermal growth factor receptor inhibitors: report of 3 cases. Dermatitis (2012) 0.85
The risk of herpes zoster in the anti-TNF-α era: a case report and review of the literature. J Dermatol Case Rep (2013) 0.85
Mutations in lipase H cause autosomal recessive hypotrichosis simplex with woolly hair. J Am Acad Dermatol (2009) 0.85
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis. Bone (2011) 0.85
Medical history, drug exposure and the risk of psoriasis. Evidence from an Italian case-control study. Dermatology (2008) 0.84
Alopecia secondary to mesotherapy. J Am Acad Dermatol (2009) 0.84
Cancrum oris in a boy with Down syndrome. J Am Acad Dermatol (2011) 0.84
Effects of palladium nanoparticles on the cytokine release from peripheral blood mononuclear cells of palladium-sensitized women. J Occup Environ Med (2011) 0.83
Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis. Immunopharmacol Immunotoxicol (2012) 0.83
Transmission of nonviral sexually transmitted infections and oral sex. J Sex Med (2011) 0.83
Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids. Contact Dermatitis (2013) 0.83
Immunopathogenesis of psoriasis and pharmacological perspectives. J Rheumatol Suppl (2009) 0.83
Managing moderate-to-severe psoriasis in the elderly. Drugs Aging (2014) 0.83
Human placenta and markers of heavy metals exposure. Environ Health Perspect (2013) 0.82
Allergic contact cheilitis. Contact Dermatitis (2006) 0.82
Resveratrol-containing gel for the treatment of acne vulgaris: a single-blind, vehicle-controlled, pilot study. Am J Clin Dermatol (2011) 0.82
Osteopontin: a new emerging role in psoriasis. Arch Dermatol Res (2009) 0.82
Cracked mercury dental amalgam as a possible cause of fever of unknown origin: a case report. J Med Case Rep (2008) 0.82
Allergic contact dermatitis from 2-ethylhexyl acrylate contained in a wig-fixing adhesive tape and its 'incidental' therapeutic effect on alopecia areata. Contact Dermatitis (2008) 0.82
Effect of a nutritional supplement on hair loss in women. J Cosmet Dermatol (2015) 0.82
Interleukin-1 family members are enhanced in psoriasis and suppressed by vitamin D and retinoic acid. Arch Dermatol Res (2013) 0.81
Psoriatic disease and tuberculosis nowadays. Clin Dev Immunol (2012) 0.81
Urticarial lesions: if not urticaria, what else? The differential diagnosis of urticaria: part I. Cutaneous diseases. J Am Acad Dermatol (2010) 0.81
Sensitization to palladium in Europe. Contact Dermatitis (2014) 0.81
Effects of climate changes on skin diseases. Expert Rev Anti Infect Ther (2014) 0.81
Kenogen. A new phase of the hair cycle? Dermatology (2002) 0.81
Quantitative determination of haptoglobin glycoform variants in psoriasis. Biol Chem (2010) 0.81
Titanium allergy associated with dental implant failure. Clin Oral Implants Res (2009) 0.81
Modification of osteopontin and MMP-9 levels in patients with psoriasis on anti-TNF-α therapy. Arch Dermatol Res (2012) 0.80
Serum antibodies against human intracisternal A-type particle (HIAP) endogenous retrovirus in Alopecia areata patients: a hallmark of autoimmune disease? J Invest Dermatol (2004) 0.80
Sensitization to palladium and nickel in Europe and the relationship with oral disease and dental alloys. Contact Dermatitis (2015) 0.80
Clinical and epidemiological features of textile contact dermatitis: an Italian multicentre study. Contact Dermatitis (2014) 0.80
Nickel, palladium and rhodium induced IFN-gamma and IL-10 production as assessed by in vitro ELISpot-analysis in contact dermatitis patients. BMC Immunol (2008) 0.80
Resveratrol regulates p66Shc activation in HaCaT cells. Exp Dermatol (2010) 0.80
Evaluation of allergic vesicular reaction to patch test using in vivo confocal microscopy. Skin Res Technol (2011) 0.80
Assessment of T regulatory cells and expanded profiling of autoantibodies may offer novel biomarkers for the clinical management of systemic sclerosis and undifferentiated connective tissue disease. Clin Dev Immunol (2013) 0.79
Analysis of the ORFK1 hypervariable regions reveal distinct HHV-8 clustering in Kaposi's sarcoma and non-Kaposi's cases. J Exp Clin Cancer Res (2015) 0.79
Folliculotropic mycosis fungoides masquerading as alopecia areata. J Am Acad Dermatol (2010) 0.79
Increased cysteinyldopa plasma levels hint to melanocyte as stress sensor in psoriasis. Exp Dermatol (2011) 0.79
"Pseudo-bullous" Kaposi's sarcoma. Eur J Dermatol (2008) 0.79
Effect of weather and environmental factors on the clinical course of psoriasis. Occup Environ Med (2013) 0.79
Contact sensitivity to hair dyes can be detected by the consumer open test. Eur J Dermatol (2002) 0.79
Efficacy of oral hyposensitization in allergic contact dermatitis caused by nickel. Contact Dermatitis (2011) 0.79
Nanocarriers for topical administration of resveratrol: a comparative study. Int J Pharm (2012) 0.79
Medicine forgets dentistry. Lancet (2005) 0.79
Photodynamic therapy to treat periimplantitis. Implant Dent (2013) 0.79
Do hair density and thickness correlate with the Hamilton scale? Arch Dermatol (2002) 0.78
Drug reaction with eosinophilia and systemic symptoms caused by lenalidomide. Eur J Dermatol (2012) 0.78
High-resolution color-Doppler ultrasound for the study of skin growths. Arch Dermatol Res (2015) 0.78
Tacrolimus does not alter the production of several cytokines and antimicrobial peptide in Malassezia furfur-infected-keratinocytes. Mycoses (2013) 0.78
Sodium dehydroacetate: an emerging allergen. Dermatitis (2012) 0.78
Reflectance confocal microscopy of the yellow dot pattern in alopecia areata. Arch Dermatol (2011) 0.78